Matthew Ingham
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma (NCT03880123) | Matthew Ingham | 2020-11-01 |
Track Matthew Ingham automatically
Every clearance here is in the API, with alerts when new ones post.